Skip to main content
. 2021 Sep 3;4(9):e2123930. doi: 10.1001/jamanetworkopen.2021.23930

Figure 1. Flow Diagram of CBD Transdermal Gel in DEE Trial.

Figure 1.

CBD, indicates cannabidiol; DEE, developmental and epileptic encephalopathies; FIAS, focal impaired awareness seizures; TCS, tonic-clonic seizues; and ZYN002, transdermal cannabidiol (Zynerba Pharmaceuticals).